vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Lovesac Co (LOVE). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $150.2M, roughly 1.1× Lovesac Co). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 0.2%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -22.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
The Lovesac Company is an American furniture retailer, specializing in a patented modular furniture system called Sactionals. Sactionals consist of two combinable pieces, “Seats” and “Sides,” as well as custom-fit covers and associated accessories. Lovesac also sells Sacs, a bag seat filled with a proprietary foam mixture.
ESPR vs LOVE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $150.2M |
| Net Profit | — | $-10.6M |
| Gross Margin | — | 56.1% |
| Operating Margin | 50.6% | -10.5% |
| Net Margin | — | -7.0% |
| Revenue YoY | 143.7% | 0.2% |
| Net Profit YoY | — | -114.0% |
| EPS (diluted) | $0.32 | $-0.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $150.2M | ||
| Q3 25 | $87.3M | $160.5M | ||
| Q2 25 | $82.4M | $138.4M | ||
| Q1 25 | $65.0M | $241.5M | ||
| Q4 24 | $69.1M | $149.9M | ||
| Q3 24 | $51.6M | $156.6M | ||
| Q2 24 | $73.8M | $132.6M | ||
| Q1 24 | $137.7M | $250.5M |
| Q4 25 | — | $-10.6M | ||
| Q3 25 | $-31.3M | $-6.7M | ||
| Q2 25 | $-12.7M | $-10.8M | ||
| Q1 25 | $-40.5M | $35.3M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | $-29.5M | $-5.9M | ||
| Q2 24 | $-61.9M | $-13.0M | ||
| Q1 24 | $61.0M | $31.0M |
| Q4 25 | — | 56.1% | ||
| Q3 25 | — | 56.4% | ||
| Q2 25 | — | 53.7% | ||
| Q1 25 | — | 60.4% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 59.0% | ||
| Q2 24 | — | 54.3% | ||
| Q1 24 | — | 59.7% |
| Q4 25 | 50.6% | -10.5% | ||
| Q3 25 | -11.4% | -5.5% | ||
| Q2 25 | 8.6% | -10.8% | ||
| Q1 25 | -34.0% | 19.7% | ||
| Q4 24 | -6.4% | -5.2% | ||
| Q3 24 | -31.0% | -5.3% | ||
| Q2 24 | 3.5% | -13.5% | ||
| Q1 24 | 52.5% | 16.1% |
| Q4 25 | — | -7.0% | ||
| Q3 25 | -35.9% | -4.1% | ||
| Q2 25 | -15.4% | -7.8% | ||
| Q1 25 | -62.2% | 14.6% | ||
| Q4 24 | — | -3.3% | ||
| Q3 24 | -57.2% | -3.7% | ||
| Q2 24 | -83.9% | -9.8% | ||
| Q1 24 | 44.3% | 12.4% |
| Q4 25 | $0.32 | $-0.72 | ||
| Q3 25 | $-0.16 | $-0.45 | ||
| Q2 25 | $-0.06 | $-0.73 | ||
| Q1 25 | $-0.21 | $2.22 | ||
| Q4 24 | $-0.14 | $-0.32 | ||
| Q3 24 | $-0.15 | $-0.38 | ||
| Q2 24 | $-0.33 | $-0.83 | ||
| Q1 24 | $0.34 | $1.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $23.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $189.3M |
| Total Assets | $465.9M | $495.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $23.7M | ||
| Q3 25 | $92.4M | $34.2M | ||
| Q2 25 | $86.1M | $26.9M | ||
| Q1 25 | $114.6M | $83.7M | ||
| Q4 24 | $144.8M | $61.7M | ||
| Q3 24 | $144.7M | $72.1M | ||
| Q2 24 | $189.3M | $72.4M | ||
| Q1 24 | $226.6M | $87.0M |
| Q4 25 | $-302.0M | $189.3M | ||
| Q3 25 | $-451.4M | $197.5M | ||
| Q2 25 | $-433.5M | $201.2M | ||
| Q1 25 | $-426.2M | $216.4M | ||
| Q4 24 | $-388.7M | $196.5M | ||
| Q3 24 | $-370.2M | $202.1M | ||
| Q2 24 | $-344.2M | $205.3M | ||
| Q1 24 | $-294.3M | $217.5M |
| Q4 25 | $465.9M | $495.5M | ||
| Q3 25 | $364.0M | $493.7M | ||
| Q2 25 | $347.1M | $483.7M | ||
| Q1 25 | $324.0M | $532.3M | ||
| Q4 24 | $343.8M | $499.7M | ||
| Q3 24 | $314.1M | $481.1M | ||
| Q2 24 | $352.3M | $477.2M | ||
| Q1 24 | $373.1M | $482.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $-4.9M |
| Free Cash FlowOCF − Capex | — | $-10.2M |
| FCF MarginFCF / Revenue | — | -6.8% |
| Capex IntensityCapex / Revenue | 0.0% | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $-4.9M | ||
| Q3 25 | $-4.3M | $12.2M | ||
| Q2 25 | $-31.4M | $-41.4M | ||
| Q1 25 | $-22.6M | $44.0M | ||
| Q4 24 | $-35.0M | $-4.2M | ||
| Q3 24 | $-35.3M | $6.2M | ||
| Q2 24 | $-7.2M | $-7.0M | ||
| Q1 24 | $53.8M | $56.3M |
| Q4 25 | — | $-10.2M | ||
| Q3 25 | — | $7.8M | ||
| Q2 25 | — | $-50.0M | ||
| Q1 25 | — | $38.7M | ||
| Q4 24 | — | $-6.6M | ||
| Q3 24 | $-35.5M | $119.0K | ||
| Q2 24 | $-7.3M | $-14.3M | ||
| Q1 24 | $53.8M | $49.5M |
| Q4 25 | — | -6.8% | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | — | -36.1% | ||
| Q1 25 | — | 16.0% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | -68.7% | 0.1% | ||
| Q2 24 | -9.9% | -10.8% | ||
| Q1 24 | 39.0% | 19.8% |
| Q4 25 | 0.0% | 3.5% | ||
| Q3 25 | 0.0% | 2.7% | ||
| Q2 25 | 0.0% | 6.2% | ||
| Q1 25 | 0.0% | 2.2% | ||
| Q4 24 | 0.0% | 1.6% | ||
| Q3 24 | 0.3% | 3.9% | ||
| Q2 24 | 0.1% | 5.5% | ||
| Q1 24 | 0.1% | 2.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | 1.82× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
LOVE
| Showrooms | $102.7M | 68% |
| Internet | $37.3M | 25% |
| Other | $10.2M | 7% |
